By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Calando Pharmaceuticals, Inc. 

129 N. Hill Avenue
Suite 104
Pasadena  California  91106  U.S.A.
Phone: 626-683-7200 Fax: 626-683-7220


Company News
Arrowhead Research Corporation (ARWR) Announces Oncology Expert Timothy J. Triche to Join Calando Pharmaceuticals, Inc. Scientific Advisory Board 7/26/2011 8:45:38 AM
Arrowhead Research Corporation (ARWR) Increases Investment in RNAi Subsidiary Calando Pharmaceuticals, Inc. 1/18/2011 10:51:56 AM
Arrowhead Research Corporation (ARWR) Increases Ownership in RNAi Subsidiary Calando Pharmaceuticals, Inc. 9/23/2010 10:24:07 AM
Arrowhead Research Corporation (ARWR) Announces Clinical Data Presentations at the 2010 American Society of Clinical Oncology Annual Meeting on June 6, 2010 6/1/2010 11:10:50 AM
Arrowhead Research Corporation (ARWR) Subsidiary, Calando Pharmaceuticals, Inc., Provides First Proof of RNA Interference in Humans with Systemically Administered siRNA Therapeutic; Clinical Trial Results Published in Nature 3/22/2010 9:18:53 AM
Arrowhead Research Corporation (ARWR) Subsidiary Calando Pharmaceuticals, Inc. Expands Board of Directors 11/4/2009 9:15:05 AM
Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation (ARWR) 6/23/2009 3:43:33 PM
Calando Pharmaceuticals, Inc. Publishes New Results of siRNA Delivery Using Its RONDEL(TM) Technology in Sepsis 12/8/2008 9:29:41 AM
Calando Pharmaceuticals, Inc. to Present at 19th Annual Oppenheimer Healthcare Conference on November 4, 2008 11/3/2008 10:32:02 AM
Calando Pharmaceuticals, Inc. Announces Completion of IT-101 Phase 1 Clinical Study 10/23/2008 9:57:08 AM